Updates on prevention and treatment of melanoma: Pharmacist involvements and challenges

Melanoma is a skin cancer that represents an actual public health problem. Its incidence is increasing every year. Environmental risk factors have been clearly identified. Early diagnosis of a suspicious skin lesion should be possible by any health professionals because the prognosis is correlated w...

Full description

Saved in:
Bibliographic Details
Published inAnnales pharmaceutiques françaises Vol. 74; no. 5; p. 335
Main Authors Slimano, F, Roessle, C, Blanc, C, De Maleissye, M-F, Bauler, S
Format Journal Article
LanguageFrench
Published France 01.09.2016
Subjects
Humans
Melanoma - prevention & control
Pharmacists
Primary Prevention
Risk Factors
Secondary Prevention
Skin Neoplasms - prevention & control
Molecular targeted therapy
Pharmacien
Prevention and control
Immunotherapy
Mélanome
Melanoma
Prévention
Thérapie ciblée
Pharmacist
Immunothérapie
Online AccessGet more information

Cover

More Information
Summary:Melanoma is a skin cancer that represents an actual public health problem. Its incidence is increasing every year. Environmental risk factors have been clearly identified. Early diagnosis of a suspicious skin lesion should be possible by any health professionals because the prognosis is correlated with the evolution of the disease and the presence of metastases. The advent of new therapies in metastatic forms with the development of immunotherapies and kinases inhibitors has significantly changed the management of this disease. New therapies are available in retail pharmacies and involve health professionals out of the hospital. This article is intended for community and hospital pharmacists and summarizes recommendations for primary and secondary prevention. It updates on new targeted therapies. It wants to give advices to the community pharmacists about the effective use of those treatments for melanoma.
ISSN:0003-4509
DOI:10.1016/j.pharma.2016.01.002